Optimal Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.03M Buy
1,812
+2
+0.1% +$1.1K 0.13% 228
2021
Q2
$913K Hold
1,810
0.11% 259
2021
Q1
$826K Sell
1,810
-3,500
-66% -$1.67M 0.11% 256
2020
Q4
$2.47M Hold
5,310
0.35% 89
2020
Q3
$2.35M Buy
5,310
+82
+2% +$33.9K 0.34% 91
2020
Q2
$1.89M Sell
5,228
-5,998
-53% -$2.01M 0.31% 118
2020
Q1
$3.18K Buy
11,226
+2,586
+30% +$815K 0.3% 109
2019
Q4
$2.81M Buy
+8,640
New +$2.62M 0.43% 66

Other funds holding TMO

Optimal Asset Management's TMO Position: Q3 2021 in Review

Optimal Asset Management increased its Thermo Fisher Scientific (TMO) stake by 0.11% in Q3 2021, buying an estimated $1.1K and bringing the position to 1,812 shares worth $1.03M. The position accounts for 0.13% of the portfolio, ranked #228.

Optimal Asset Management first reported a position in TMO in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.81M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Optimal Asset Management held 1,812 shares of Thermo Fisher Scientific worth $1.03M as of Q3 2021.
  • Optimal Asset Management bought 2 Thermo Fisher Scientific shares in Q3 2021, an estimated $1.1K.
  • Thermo Fisher Scientific made up 0.13% of Optimal Asset Management's portfolio in Q3 2021, its #228 holding.
  • Optimal Asset Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 8 quarters since.
  • Optimal Asset Management's Thermo Fisher Scientific position peaked at $2.81M in Q4 2019.
  • 2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.